- Alessia Cucci, University of Piemonte Orientale, Italy
Functional and transcriptomic approaches on endothelial cell behavior in response to coagulation factors - Tirsa van Duijl, Sanquin Research, The Netherlands
Molecular footprints of haemostatic disorders - Dario Balestra, University of Ferrara, Italy
Prime Editor nuclease-mediated Translocation and Inversions (PETI) to correct the most common hemophilia A mutation - Yohei Hisada, University of North Carolina, United States
The role of the podoplanin-C-type lectin-like receptor 2 pathway in thrombocytopenia and bleeding in acute promyelocytic leukemia - Maria Francesca Testa, University of Ferrara, Italy
Tailored RNA-therapeutic molecules over recurrent nonsense mutations in hemophilia A
Professor Heimburger Award
Celebrating Science
Professor Dr. Norbert Heimburger, a CSL employee for over three decades, was a pioneer of modern coagulation therapy. Among his many achievements, Prof. Dr. Heimburger developed virus-safe plasma products based on pasteurization, including launching the first effectively virus-inactivated FVIII concentrate in 1981.
In his honor, CSL created the Heimburger Award to recognize the clinical and/or preclinical research of emerging coagulation specialists who are driven to improve the care of patients with bleeding disorders.